Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics John P. HaysMaria Jose Ruiz-Alvarezthe Global AMR Insights Ambassador Network Commentary Open access 23 May 2022 Pages: 1315 - 1326
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic E. Ariza-VioqueF. ElloINTENSE-TBM Group Commentary Open access 29 June 2022 Pages: 1327 - 1341
Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review Selim BadurMansour KhalafAtef Shibl Review Open access 19 May 2022 Pages: 1343 - 1369
Climate Change and Cascading Risks from Infectious Disease Jan C. SemenzaJoacim RocklövKristie L. Ebi Review Open access 19 May 2022 Pages: 1371 - 1390
Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review Norka I. NapuriDaniel CurcioAmit Srivastava Review Open access 25 May 2022 Pages: 1391 - 1414
Laparoscopic Treatment Strategies for Liver Echinococcosis Li WanTao WangQianjun Yu Review Open access 25 June 2022 Pages: 1415 - 1426
Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China Yuanyuan SongYuchang LiJing Sun Review Open access 11 July 2022 Pages: 1427 - 1442
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms Joe YangJaesh NaikRyan James Dillon Original Research Open access 25 March 2022 Pages: 1443 - 1457
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms Joe YangJaesh NaikRyan James Dillon Correction Open access 24 June 2022 Pages: 1459 - 1460
Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients Xiaoxia WuGuo LongQiquan Wan Original Research Open access 13 May 2022 Pages: 1461 - 1477
Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015 Young June ChoeEmmanuel VidorChristine Manson Original Research Open access 14 May 2022 Pages: 1479 - 1492
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study Szu-Min HsiehShan-Chwen ChangChia En Lien Original Research Open access 17 May 2022 Pages: 1493 - 1504
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study Tanya BabichPontus NauclerDafna Yahav Original Research Open access 25 May 2022 Pages: 1505 - 1519
Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed? Guillaume BéraudSarah Tubianathe COMBAT study group Original Research Open access 26 May 2022 Pages: 1521 - 1540
Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota Pablo Villoslada-BlancoPatricia Pérez-MatuteJosé A. Oteo Original Research Open access 26 May 2022 Pages: 1541 - 1557
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia Giovanni LandoniLorenzo PiemontiFlavio Mantelli Original Research Open access 26 May 2022 Pages: 1559 - 1574
Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China Yihong ZhouYuanyuan QinYaokai Chen Original Research Open access 11 June 2022 Pages: 1575 - 1590
Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients Yang DengJun-Yuan GuGui-Ying Xiao Original Research Open access 11 June 2022 Pages: 1591 - 1608
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections L. Ostrosky-ZeichnerM. H. NguyenG. R. Thompson III Original Research Open access 18 June 2022 Pages: 1609 - 1629
Clinical Characteristics of Chlamydia psittaci Pneumonia Infection in Central South China Min YangDan-Hui YangHong Luo Original Research Open access 20 June 2022 Pages: 1631 - 1647
Linezolid vs Vancomycin in Induced Thrombocytopenia Dimah Al-HarbiAbdulrahman AlturaikiLaila Carolina Abu Esba Original Research Open access 21 June 2022 Pages: 1649 - 1660
Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis Jing XieBin XuWei Liu Original Research Open access 24 June 2022 Pages: 1661 - 1682
Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA Kenneth J. SmithAngela R. WateskaRichard K. Zimmerman Original Research Open access 13 July 2022 Pages: 1683 - 1693
Explainable Machine-Learning Model for Prediction of In-Hospital Mortality in Septic Patients Requiring Intensive Care Unit Readmission Chang HuLu LiZhiyong Peng Original Research Open access 14 July 2022 Pages: 1695 - 1713
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens Taylor MorrisetteSara AlosaimyMichael J. Rybak Brief Report Open access 14 May 2022 Pages: 1715 - 1723
Genomic Epidemiology of MBL-Producing Pseudomonas putida Group Isolates in Poland Paweł UrbanowiczRadosław IzdebskiMarek Gniadkowski Brief Report Open access 10 June 2022 Pages: 1725 - 1740
Potential of Continuous Local Antibiotic Perfusion Therapy for Fracture-Related Infections Kenji KosugiYukichi ZenkeAkinori Sakai Case Series Open access 21 May 2022 Pages: 1741 - 1755
Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants” Jorge A. GomezJavier Nieto GuevaraEdwin Rodriguez Letter Open access 16 May 2022 Pages: 1757 - 1761
Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants” Johnna PerdrizetEmily HornAnna Ong-Lim Letter Open access 16 May 2022 Pages: 1763 - 1765
Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection Eszter FodorVeronika MüllerZsombor Lacza Correction Open access 16 May 2022 Pages: 1767 - 1768